People infected with potentially fatal hepatitis C from tainted blood are pushing Ontario to make them whole by paying for expensive breakthrough drugs considered a virtual cure for the liver disease.
Ontario’s health ministry says 341 Ontarians with
stage-two liver disease or worse get Sovaldi or Harvoni pills funded by
taxpayers — $60,000 for a 12-week course — under an exceptional access
The medications are light-years ahead of
previous pharmaceuticals that had troubling side effects and did not
work nearly as well.
Doctors say the triage system, in which a FibroScan (a non-invasive
liver test) must meet or exceed a specific level of liver damage, can
miss patients with complications that would otherwise make them eligible
for taxpayer coverage.
Labels: access to care, Canada, Ontario, treatment criteria